Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Meehan

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Immunological Investigations|December 29, 2007
Dye dilution proliferation assay: application of the DDPA to identify tumor-specific T cell precursor frequencies in clinical trialsThomas Schwaab, Jan L Fisher, Kenneth R Meehan, et al.
Transfusion|April 6, 2006
Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilizationKenneth R Meehan, John M Hill, Linda Patchett, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
The Journal of Community and Supportive Oncology|February 10, 2016
Hospital readmission following transplantation: identifying risk factors and designing preventive measuresDorothy R McKenna, Matthew R Sullivan, John M Hill, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patientsKenneth R Meehan, Rebecca Slack, Edmund Gehan, et al.
Journal of Clinical Apheresis|December 2, 2017
Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilizationSwaroopa Yerrabothala, Laleh Talebian, Karen Klinker, et al.
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Novel mobilization strategies to enhance autologous immune effector cells in multiple myelomaLaleh Talebian, Jia Yan Wu, Dawn A Fischer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Immunological Investigations|December 29, 2007
Dye dilution proliferation assay: application of the DDPA to identify tumor-specific T cell precursor frequencies in clinical trialsThomas Schwaab, Jan L Fisher, Kenneth R Meehan, et al.
Transfusion|April 6, 2006
Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilizationKenneth R Meehan, John M Hill, Linda Patchett, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
The Journal of Community and Supportive Oncology|February 10, 2016
Hospital readmission following transplantation: identifying risk factors and designing preventive measuresDorothy R McKenna, Matthew R Sullivan, John M Hill, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patientsKenneth R Meehan, Rebecca Slack, Edmund Gehan, et al.
Journal of Clinical Apheresis|December 2, 2017
Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilizationSwaroopa Yerrabothala, Laleh Talebian, Karen Klinker, et al.
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Novel mobilization strategies to enhance autologous immune effector cells in multiple myelomaLaleh Talebian, Jia Yan Wu, Dawn A Fischer, et al.
Pageof 4